Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Neuropeptide B (NPB) is an endogenous ligand of G-protein-coupled receptor 7 (GP7) and G-protein-coupled receptor 8 (GPR8) identified in 2002. It is a unique nitrogen-terminal tryptophan C-6 brominated peptide with a structure similar to the neuropeptide W. In vitro pharmacological studies have found that NPB is only a high affinity ligand for GP7.
NPB Expression
In the central nervous system, in situ hybridization revealed that mouse NPB precursor mRNA was expressed in the hippocampal CA1-CA3 region, lateral phrenic nucleus, hypothalamic paraventricular nucleus (PVN), and some nucleus groups in the midbrain and brainstem. This includes the E. Westfal nucleus (EW nucleus), blue spots, lateral parabrachial nucleus, etc., among which the EW nucleus expresses the most. Immunohistochemistry and fluorescence showed that there were NPB immunoreactive (irNPB) cells in multiple regions of the hypothalamus. In peripheral tissues, RT-PCR showed that human NBMB mRNA was expressed in kidney, testis, uterus, ovary and placenta. The expression of NPB mRNA in the stomach, spinal cord, and testis was detected by Northern blot, but it was less expressed in liver and kidney. NPB immunocompetent cells were also found in isolated islet cells from rats, and ppNPB and NPWR1-like mRNAs were expressed.
Figure 1. The ligand-receptor pair(s) in chickens, humans, and zebrafish. (Bu, G., et al. 2016)
NPB and Biological Rhythm
NPB and GP7mRNA show a high degree of supraoptic nucleus (SCN), and NPB also has a strong signal there, suggesting that NPB and its receptor GP7 may participate in the regulation of biological rhythm. Studies have found that NPB has a two-way regulatory effect on food intake and is affected by CRF. At the same time, NPB also participates in regulating the hypothalamus-pituitary-adrenal (HPA) cortex axis. In the light and dark phases, NPB was injected through the lateral ventricle, and it was found that NPB reduced the spontaneous activity of mice in the dark phase. EEG and EMG measurements also showed that at this time NPB increased slow wave sleep (SWS) in mice, while heterophasic sleep was not affected, and the spectral power of NPB-induced slow wave sleep was similar to physiology. NPB immunopositive cells were present in the ventral tegmental area (VTA) and substantia nigra (SN) of the midbrain, and co-expressed with tyrosine hydroxylase-positive neurons (possibly dopaminergic neurons). Dopamine is an important neurological substance regulating sleep-wake, suggesting that in the midbrain, NPB may interact with dopaminergic neurons to participate in the regulation of sleep-wake.
NPB and Energy Metabolism
The regulation of NPB on feeding behavior is more complicated. Intravenous injection of NPB in conscious mice during the dark period found that in the initial 2 h low dose (3 nmol) induced increased food intake, but high doses inhibited food intake, and the two doses of NPB both suppressed appetite in the subsequent period. When a known appetite-suppressing peptide, a hormone-releasing hormone-reducing factor (CRF), is injected into the ventricle in advance, the appetite suppressive effect of NPB can be significantly increased. When both CRF and NPB were given at the same time, the appetite of the mice was completely inhibited for more than 4 h, indicating that NPB has a two-way regulatory effect on food intake and that the peptide is related to food intake inhibition under stress conditions.
NPB can also increase the secretion and expression of resistin. Studies have shown that resistin can increase insulin resistance and stimulate liver glucose production, both of which can cause blood glucose concentrations to increase, suggesting that NPB can regulate blood glucose concentrations in rats. Studies have found that sleep deprivation increases appetite, reduces energy expenditure, and affects glucose metabolism. Therefore, NPB may be involved in regulating energy metabolism abnormalities caused by chronic stress such as chronic sleep restriction, especially long-term sleep restriction.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.